NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd. (NRSN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · NRSN · as of Sep 30, 2025
Ownership Breakdown
10
Institutional Holders
▼ 7 vs Q2
$346,797
Total Inst. Value
▼ $617,562 vs Q2
24.67M
Shares Outstanding
freeFloat 65.30%
277,925
13F Shares Held
▼ 232,119 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
NRSN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SQUAREPOINT OPS LLC pharmaceutical preparations | 95.4K | 37.55% | 37.55% | $119.22M | Nov 14, 2025 | ▲ 45.5K |
MORGAN STANLEY pharmaceutical preparations | 66.4K | 26.14% | 26.14% | $83.00M | May 27, 2026 | ▼ 13.5K |
MEITAV INVESTMENT HOUSE LTD pharmaceutical preparations | 40.0K | 15.75% | 15.75% | $50.00M | Oct 29, 2025 | — held |
TWO SIGMA INVESTMENTS, LP pharmaceutical preparations | 21.1K | 8.30% | 8.30% | $26.36M | Nov 14, 2025 | NEW |
COMMONWEALTH EQUITY SERVICES, LLC pharmaceutical preparations | 21.1K | 8.30% | 8.30% | $26.00M | Oct 22, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 15.9K | 6.25% | 6.25% | $19.84M | Nov 12, 2025 | — held |
UBS GROUP AG pharmaceutical preparations | 14.7K | 5.77% | 5.77% | $18.32M | Nov 13, 2025 | ▲ 13.0K |
SBI SECURITIES CO., LTD. pharmaceutical preparations | 1.5K | 0.57% | 0.57% | $1.82M | Nov 5, 2025 | ▼ 3.0K |
JONES FINANCIAL COMPANIES LLLP pharmaceutical preparations | 1.0K | 0.39% | 0.39% | $1.24M | Nov 4, 2025 | ▼ 9.9K |
CWM, LLC pharmaceutical preparations | 1.0K | 0.39% | 0.39% | $1.00M | Oct 15, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
2
Increased
+58.5K shares1
New Positions
first time holders3
Decreased
−26.4K shares8
Sold Out
fully exitedNet shares change (top 50)
+32.1K
+58.5K / −26.4K
Net new holders
-8
1 new / 8 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
NRSN insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Eisenberg Or Chief Financial Officer | Mar 26, 2026 | Award | 200,000 | — | — | 1.25M | Form 4 ↗ |
Russek-Blum Niva Chief Technology Officer | Mar 26, 2026 | Award | 200,000 | — | — | 468.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
NeuroSense Therapeutics Ltd. (NRSN) is primarily owned by institutional investors, who hold approximately 1.1% of total shares outstanding. Company insiders own approximately 34.70%, while retail and public investors account for the remaining 64.18%.
The largest institutional shareholder of NeuroSense Therapeutics Ltd. is SQUAREPOINT OPS LLC, holding approximately 95,375 shares — equal to 37.55% of outstanding shares — as of September 30, 2025.
A total of 10 institutional investors currently hold NRSN stock, with a combined institutional value of approximately $346,797 as of the most recent 13F filing period.
Frequently asked questions
NRSN ownershipNeuroSense Therapeutics Ltd. (NRSN) is primarily owned by institutional investors, who hold approximately 1.1% of shares. The largest shareholder is SQUAREPOINT OPS LLC with a 37.55% stake. Company insiders hold 34.70%. Data sourced from SEC Form 13F as of September 30, 2025.